See more : Lindsay Australia Limited (LAU.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Hofseth BioCare ASA (HBC.OL) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Hofseth BioCare ASA, a leading company in the Biotechnology industry within the Healthcare sector.
- First Watch Restaurant Group, Inc. (FWRG) Income Statement Analysis – Financial Results
- Heads UP Ventures Limited (HEADSUP.NS) Income Statement Analysis – Financial Results
- Haining China Leather Market Co.,Ltd (002344.SZ) Income Statement Analysis – Financial Results
- Imerys S.A. (IMYSY) Income Statement Analysis – Financial Results
- General Elevator Co., Ltd (300931.SZ) Income Statement Analysis – Financial Results
Hofseth BioCare ASA (HBC.OL)
About Hofseth BioCare ASA
Hofseth BioCare ASA engages in providing value added biomarine ingredients for human and animal applications in Norway and internationally. Its products include Brilliant salmon oil; OmeGo salmon oil for the maintenance of healthy cholesterol and cardiovascular function; ProGo, a salmon protein hydrolysate powder used as a fast absorbing protein supplement; CalGo, a marine calcium powder produced to support cartilage function and joint health; CollaGo, a collagen peptide powder to enhance the beauty of hair, skin, and nails; and PetGo, a non-soluble protein. The company distributes its products through distributors, agents, and its own sales force. It has a research agreement with Stanford University School of Medicine for pre-clinical and clinical research on necrotizing enterocolitis and irritable bowel syndrome. The company was founded in 2000 and is headquartered in Ålesund, Norway.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 194.87M | 120.45M | 87.62M | 69.25M | 67.78M | 60.74M | 118.48M | 20.20M | 55.14M | 19.77M | 62.94M | 26.02M | 1.18M | 171.00K |
| Cost of Revenue | 150.69M | 91.93M | 64.52M | 39.53M | 59.57M | 48.36M | 54.93M | 101.41M | 65.37M | 14.62M | 25.31M | 23.96M | 462.00K | 0.00 |
| Gross Profit | 44.19M | 28.51M | 23.10M | 29.72M | 8.21M | 12.38M | 63.55M | -81.21M | -10.24M | 5.15M | 37.62M | 2.05M | 721.00K | 171.00K |
| Gross Profit Ratio | 22.67% | 23.67% | 26.36% | 42.92% | 12.11% | 20.38% | 53.64% | -401.93% | -18.56% | 26.05% | 59.78% | 7.89% | 60.95% | 100.00% |
| Research & Development | 11.01M | 13.64M | 12.53M | 7.56M | 131.00K | 2.43M | 1.30M | 1.79M | 4.38M | 2.82M | 1.69M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 21.99M | 17.87M | 31.82M | 18.67M | 8.02M | 5.54M | 5.64M | 7.33M | 9.64M | 10.19M | 12.57M | 11.60M | 0.00 | 0.00 |
| Selling & Marketing | 13.49M | 15.04M | 13.03M | 7.86M | 4.30M | 2.23M | 754.00K | 1.81M | 2.74M | 1.34M | 957.00K | 1.37M | 0.00 | 0.00 |
| SG&A | 65.48M | 32.91M | 44.85M | 26.54M | 12.32M | 7.76M | 6.40M | 9.14M | 12.39M | 11.53M | 13.53M | 12.96M | 0.00 | 0.00 |
| Other Expenses | 70.22M | 1.56M | 0.00 | -86.00K | -8.93M | 0.00 | -777.00K | -892.00K | -1.22M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 146.72M | 157.13M | 141.66M | 121.83M | 88.56M | 90.86M | 75.52M | 64.25M | 84.33M | 69.56M | 86.57M | 60.10M | 25.04M | 13.08M |
| Cost & Expenses | 297.40M | 249.07M | 206.18M | 161.36M | 148.13M | 139.22M | 130.45M | 165.66M | 149.70M | 84.18M | 111.88M | 84.06M | 25.50M | 13.08M |
| Interest Income | 550.00K | 651.00K | 613.00K | 553.00K | 510.00K | 209.00K | 100.00K | 381.00K | 47.00K | 42.00K | 30.00K | 59.00K | 102.00K | -3.00K |
| Interest Expense | 7.54M | 9.95M | 9.39M | 9.22M | 8.57M | 3.83M | 3.32M | 10.35M | 9.39M | 7.07M | 5.63M | 5.06M | 1.44M | 131.00K |
| Depreciation & Amortization | 36.41M | 30.22M | 29.35M | 23.81M | 25.15M | 22.19M | 21.70M | 18.57M | 18.59M | 14.05M | 12.56M | 7.91M | 1.66M | -76.00K |
| EBITDA | -70.60M | -97.01M | -85.57M | -68.28M | -55.49M | -58.51M | 8.54M | -118.54M | -74.28M | -44.60M | -32.52M | -50.02M | -22.62M | -12.83M |
| EBITDA Ratio | -36.23% | -80.55% | -100.12% | -95.68% | -78.77% | -94.09% | 7.20% | -570.20% | -130.99% | -212.46% | -56.44% | -192.28% | -1,825.36% | -7,502.34% |
| Operating Income | -102.53M | -128.62M | -118.57M | -92.02M | -79.57M | -77.70M | -11.20M | -144.56M | -93.35M | -63.22M | -47.49M | -58.04M | -24.32M | -12.91M |
| Operating Income Ratio | -52.61% | -106.78% | -135.32% | -132.88% | -117.40% | -127.92% | -9.45% | -715.52% | -169.30% | -319.78% | -75.45% | -223.12% | -2,055.71% | -7,546.78% |
| Total Other Income/Expenses | -4.16M | -8.77M | -7.90M | -10.07M | -9.64M | -6.83M | -5.29M | -2.90M | -6.86M | -3.72M | -4.68M | -4.95M | -1.40M | -134.00K |
| Income Before Tax | -106.68M | -137.39M | -126.46M | -102.09M | -89.22M | -84.53M | -16.48M | -147.46M | -100.20M | -66.94M | -52.17M | -63.00M | -25.71M | -13.04M |
| Income Before Tax Ratio | -54.75% | -114.07% | -144.34% | -147.42% | -131.63% | -139.16% | -13.91% | -729.85% | -181.73% | -338.61% | -82.89% | -242.15% | -2,173.63% | -7,625.15% |
| Income Tax Expense | 0.00 | 1.18M | 1.49M | -1.01M | -1.28M | 249.00K | -1.97M | 3.25M | 2.52M | 7.14M | -631.00K | 11.53M | -6.68M | -3.65M |
| Net Income | -106.68M | -137.39M | -126.46M | -102.09M | -89.21M | -84.77M | -16.48M | -147.45M | -100.19M | -66.92M | -52.14M | -73.86M | -19.04M | -9.39M |
| Net Income Ratio | -54.74% | -114.06% | -144.34% | -147.42% | -131.62% | -139.56% | -13.91% | -729.81% | -181.72% | -338.50% | -82.84% | -283.91% | -1,609.13% | -5,489.47% |
| EPS | -0.27 | -0.37 | -0.35 | -0.31 | -0.29 | -0.33 | -0.07 | -1.01 | -0.95 | -0.73 | -0.72 | -1.29 | -0.45 | -0.33 |
| EPS Diluted | -0.27 | -0.37 | -0.35 | -0.31 | -0.29 | -0.33 | -0.07 | -1.01 | -0.94 | -0.72 | -0.70 | -1.25 | -0.43 | -0.33 |
| Weighted Avg Shares Out | 395.08M | 374.74M | 357.83M | 333.65M | 307.29M | 258.99M | 234.31M | 146.19M | 105.62M | 91.39M | 72.66M | 57.36M | 42.76M | 28.33M |
| Weighted Avg Shares Out (Dil) | 395.08M | 374.74M | 357.83M | 333.65M | 307.29M | 258.99M | 234.31M | 146.64M | 107.05M | 92.72M | 74.42M | 59.09M | 44.17M | 28.43M |
Source: https://incomestatements.info
Category: Stock Reports